These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies. Gil-Nagel A, Cross JH, Devinsky O, Ceulemans B, Lagae L, Knupp K, Schoonjans AS, Ryvlin P, Thiele EA, Polega S, Lothe A, Nabbout R. Epilepsia; 2024 Aug; 65(8):2186-2199. PubMed ID: 39030735 [Abstract] [Full Text] [Related]
4. PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis. Steinhoff BJ, Goldmann T, Kockelmann E, Winter Y, PERPRISE Study Group. Epilepsia Open; 2024 Jun; 9(3):926-939. PubMed ID: 38017663 [Abstract] [Full Text] [Related]
5. Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332. Resnick T, Patten A, Ngo LY, Malhotra M. Epilepsy Behav; 2022 Mar; 128():108528. PubMed ID: 35078116 [Abstract] [Full Text] [Related]
17. Long-term effectiveness of add-on perampanel in patients with Lennox-Gastaut syndrome: A multicenter retrospective study. Matricardi S, Cesaroni E, Bonanni P, Foschi N, D Aniello A, Di Gennaro G, Striano P, Cappanera S, Siliquini S, Freri E, Ragona F, Granata T, Deleo F, Villani F, Russo A, Messana T, Siri L, Bagnasco I, Vignoli A, Operto FF, Orsini A, Bonuccelli A, Papa A, Peruzzi C, Liguori C, Verrotti A, Chiarelli F, Marini C, Lattanzi S. Epilepsia; 2023 Jun; 64(6):e98-e104. PubMed ID: 37000415 [Abstract] [Full Text] [Related]